ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP, COO, Head of Commercial Brendan Teehan sold $92K of Acadia Pharmaceuticals Inc.
Sold$92,006
$17.90Price
5,140Shares
−12%Stake
What ACAD did after the filing
- The stock from Thu, Mar 28 open, $18.20
- −16.2%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the May 10 close.
Traded Wed, Mar 27. Filed Wed, Mar 27, 4:00 PM ET, after the close. Returns use the Mar 28 open and the May 10 close. Not investment advice.